Monitoring the humoral protective immune response and its durability after SARS-CoV-2
infections is essential for risk assessment of reinfections, the improvement of diagnostic …

Background COVID-19 prediction models based on clinical characteristics, routine biochemistry
and imaging, have been developed, but little is known on proteomic markers reflecting …

Background The currently used SARS-CoV-2 mRNA vaccines have proven to induce a
strong and protective immune response. However, functional relevance of vaccine-generated …

Background The SARS-CoV-2 pandemic is a worldwide challenge. The CRIT-CoV-U pilot
study generated a urinary proteomic biomarker consisting of 50 peptides (COV50), which …

SARS‐CoV‐2 infection results in a mild‐to‐moderate disease course in most patients,
allowing outpatient self‐care and quarantine. However, in ≈10% of cases a two‐ or three‐phasic …

Identification of significant changes in urinary peptides may enable improved understanding
of molecular disease mechanisms. We aimed towards identifying urinary peptides …

Purpose The benefits of antiviral treatment with remdesivir in hospitalized patients with
COVID-19 remain controversial. Clinical analyses are needed to demonstrate which patient …

Background Serological severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
antibody assays differ in the target antigen specificity, eg of antibodies directed against the …

Two weeks prior to the initial presentation of a 32-year-old kidney transplant patient, his cat
developed ulcerating nodules and passed away. He was scratched by his cat several times …

Simple Summary Since the outbreak of the Coronavirus Disease (COVID-19) disease in
2019 immunological research is continuing to debunk contingent pathomechanistic …